Assessment of the clinical and economic impact of advate in prophylactic treatment of hemophilia a patients. ijph [Internet]. 2012 Dec. 31 [cited 2026 Jul. 28];9(4 Suppl. 2). Available from: https://test-ojs-unimi-it.archicoop.it/index.php/ijphjournal/article/view/23476